658 results on '"Lebranchu, Y."'
Search Results
2. Rapport 21-13. Formation des chirurgiens/des équipes chirurgicales à la chirurgie robot-assistée. État de la situation actuelle. Propositions d’améliorations
3. Avis sur l’attractivité des carrières hospitalo-universitaires
4. Greffe de rein d’un donneur vivant : bilan préparatoire et suivi du donneur
5. Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Randomized Study
6. Genome-Wide Association Study of Acute Renal Graft Rejection
7. Exclusion of Patients with a Severe T-Cell Defect Improves the Definition of Common Variable Immunodeficiency
8. CMV Infection in the Donor and Increased Kidney Graft Loss: Impact of Full HLA-I Mismatch and Posttransplantation CD8+ Cell Reduction
9. Five-Year Results of a Randomized Trial Comparing De Novo Sirolimus and Cyclosporine in Renal Transplantation: The Spiesser Study
10. Epidemiology of Posttransplant Lymphoproliferative Disorders in Adult Kidney and Kidney Pancreas Recipients: Report of the French Registry and Analysis of Subgroups of Lymphomas
11. Immunosuppressant Regimen Based on Sirolimus Decreases Aortic Stiffness in Renal Transplant Recipients in Comparison to Cyclosporine
12. Efficacy and Safety of Early Cyclosporine Conversion to Sirolimus with Continued MMF—Four-Year Results of the Postconcept Study
13. Organ procurement from cadaveric children
14. Baseline differential blood count and prognosis in CD20-positive post-transplant lymphoproliferative disorder in the prospective PTLD-1 trial
15. The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant Recipients
16. Interstitial Fibrosis Quantification in Renal Transplant Recipients Randomized to Continue Cyclosporine or Convert to Sirolimus
17. PROGNOSTIC VALUE OF LOW PCR CYTOMEGALOVIRUS LOAD IN KIDNEY TRANSPLANT RECIPIENTS: 56
18. TRANSPLANTATION OF KIDNEY WITH CYTOMEGALOVIRUS (CMV) SEROPOSITIVE DONORS DURABLY AFFECTS THE LONG TERM ANTI-CMV RESPONSE IN RECIPIENTS: 57
19. ANTI-HLA ANTIBODIES AND HUMAN DENDRITIC CELL: IN VITRO EFFECTS ON CELL MATURATION AND SURVIVAL: 47
20. COMPARISON OF INTERLEUKIN-2 BLOCKADE IN KIDNEY TRANSPLANT PATIENTS RANDOMIZED TO 40 OR 80 MG BASILIXIMAB WITH CYCLOSPORINE OR 80 MG BASILIXIMAB WITH EVEROLIMUS: 46
21. Efficacy on Renal Function of Early Conversion from Cyclosporine to Sirolimus 3 Months After Renal Transplantation: Concept Study
22. Anti-CD25 Antibodies Decrease the Ability of Human Dendritic Cells to Prime Allogeneic CD4 T Cells
23. Prognostic Value of Absent End-Diastolic Flow Within the First Week Following Renal Transplantation
24. Induction of Porcine Regulatory Cells by Mycophenolic Acid-Treated Dendritic Cells
25. Impact of a Polymorphism in the IL-12p40 Gene on the Outcome of Kidney Transplantation
26. Nouvelles perspectives en immunothérapie des cancers dans les années à venir
27. Early Pulse Pressure and Low-Grade Proteinuria as Independent Long-Term Risk Factors for New-Onset Diabetes Mellitus After Kidney Transplantation
28. Structure and stability of annular sheared channel flows: effects of confinement, curvature and inertial forces – waves
29. New Approaches to De Novo Immunosuppression and Steroid Elimination
30. AADAPT- Analysis of Advagraf Dose Adaptation Post Transplantation.: Abstract# B790
31. Prognostic Value of Low PCR Cytomegalovirus Load in Kidney Transplant Recipients.: Abstract# D2452
32. Comparison of Interleukin-2 (Il-2) Blockade in Kidney Transplant Patients Randomized to 40mg or 80mg Basiliximab (BSX) With Cyclosporine (CsA) or 80mg BSX With Everolimus (EVR).: Abstract# C1801
33. The Spiesser Study: Results at 8 Years.: Abstract# B983
34. Mycophenolate mofetil in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis: a prospective pharmacokinetics and clinical study
35. Sirolimus Versus Cyclosporine in Kidney Recipients Receiving Thymoglobulin®, Mycophenolate Mofetil and a 6‐Month Course of Steroids
36. Relationship between calcineurin inhibition and plasma endothelin concentrations in cyclosporine-A-treated kidney transplant patients
37. Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome
38. Efficiency of immunoglobulin G replacement therapy in common variable immunodeficiency: correlations with clinical phenotype and polymorphism of the neonatal Fc receptor
39. Estimation of the Glomerular Filtration Rate Through Different Methods in Kidney Transplant Recipients: Correlation With the Creatinine Clearance Measurement
40. Low 1-Year Cyclosporine Microemulsion Doses Are Associated With Better 5-Year Renal Graft Function: An Insight From MOST, a Multinational Observational Study
41. Effect of Anti-Interleukin-2 Receptor Antibody on Human Dendritic Cell Maturation and Activation.: Abstract# 638: Poster Board #-Session: P106-I
42. Mothers without HLA antibodies before transplantation have a low risk of alloimmunization post-transplantation
43. LEUKOPENIA & NEUTROPENIA IN KIDNEY TRANSPLANT RECIPIENTS EXPOSED TO 200 VS. 100 DAYS OF VALGANCICLOVIR PROPHYLAXIS: A SUBANALYSIS OF THE IMPACT TRIAL: RO-165
44. EFFICACY AND SAFETY OF EARLY CYCLOSPORINE (CsA) CONVERSION TO SIROLIMUS (SRL) WITH MYCOPHENOLATE MOFETIL (MMF): 5-YEAR RESULTS OF THE POST-CONCEPT STUDY: O-201
45. Campylobacter infection in adult patients with primary antibody deficiency
46. Discussion suite à la communication : « Greffe de rein d’un donneur vivant : bilan préparatoire et suivi du donneur »
47. High Dose Epoetin Beta in the First Weeks Following Renal Transplantation and Delayed Graft Function: Results of the Neo-PDGF Study
48. The Role of Organic Anion-Transporting Polypeptides and Their Common Genetic Variants in Mycophenolic Acid Pharmacokinetics
49. Predominant Th1 and Cytotoxic Phenotype in Biopsies from Renal Transplant Recipients with Transplant Glomerulopathy
50. Poster Board #-Session: P145-II MPA Exposure in Patients with Early Steroid Withdrawal: Comparison between Two MMF Based Immunosuppressive Regimens, Concentration-Controlled Versus Fixed Dose.: Abstract# 1125
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.